Burning Rock Biotech Limited
BNR
$8.83
-$0.46-4.95%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 03/31/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 15.62M | 17.82M | 18.39M | 18.30M | 18.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.62M | 17.82M | 18.39M | 18.30M | 18.30M |
| Cost of Revenue | 4.33M | 3.91M | 4.58M | 4.91M | 4.91M |
| Gross Profit | 11.28M | 13.90M | 13.81M | 13.39M | 13.39M |
| SG&A Expenses | 10.02M | 10.68M | 10.27M | 9.93M | 9.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.34M | 19.52M | 20.64M | 20.38M | 20.38M |
| Operating Income | -2.73M | -1.70M | -2.25M | -2.09M | -2.09M |
| Income Before Tax | -2.49M | -2.05M | -2.31M | -1.83M | -1.83M |
| Income Tax Expenses | 33.60K | 123.60K | 29.60K | 30.80K | 30.80K |
| Earnings from Continuing Operations | -2.53M | -2.17M | -2.34M | -1.86M | -1.86M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.53M | -2.17M | -2.34M | -1.86M | -1.86M |
| EBIT | -2.73M | -1.70M | -2.25M | -2.09M | -2.09M |
| EBITDA | -1.94M | -935.50K | -458.90K | -320.60K | -320.60K |
| EPS Basic | -2.40 | -2.07 | -2.17 | -1.73 | -1.73 |
| Normalized Basic EPS | -0.15 | -0.12 | -0.13 | -0.11 | -0.11 |
| EPS Diluted | -2.40 | -2.07 | -2.17 | -1.73 | -1.73 |
| Normalized Diluted EPS | -0.15 | -0.12 | -0.13 | -0.11 | -0.11 |
| Average Basic Shares Outstanding | 10.52M | 10.48M | 10.77M | 10.76M | 10.76M |
| Average Diluted Shares Outstanding | 1.05M | 1.05M | 1.08M | 1.08M | 1.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |